NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
Abstract Background Lung adenocarcinoma (LUAD) is the leading cause of cancer-related death. This study aimed to develop and validate reliable prognostic biomarkers and signature. Methods Differentially expressed genes were identified based on three Gene Expression Omnibus (GEO) datasets. Based on 1...
Main Authors: | Cui Zhao, Jian Liu, Haomiao Zhou, Xin Qian, Hui Sun, Xuewen Chen, Miaosen Zheng, Tingting Bian, Lei Liu, Yifei Liu, Jianguo Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-01938-4 |
Similar Items
-
A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma
by: Jiahang Song, et al.
Published: (2021-01-01) -
Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma
by: Jie Ren, et al.
Published: (2021-01-01) -
Identification of an eight-gene prognostic signature for lung adenocarcinoma
by: Li S, et al.
Published: (2018-09-01) -
NEIL J. SMELSER: SNIPPETS OF PERSONAL MEMORY
by: Piotr SZTOMPKA
Published: (2018-11-01) -
Integrated Analysis of Cell Cycle–Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma
by: Fangyu Chen, et al.
Published: (2021-06-01)